Variability and variation in drug susceptibility among Giardia duodenalis isolates and clones exposed to 5-nitroimidazoles and benzimidazoles in vitro

Journal of Antimicrobial Chemotherapy

Volumn 54, Issue 4, 2004, Pages 711-721

  Argüello García, Raúl ^a   Cruz Soto, Maricela ^a   Romero Montoya, Lydia ^a   Ortega Pierres, Guadalupe ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

Antiprotozoal drugs; Cell morphology assays; Clonal variation; Dye uptake assays; Viability assays

Indexed keywords

5 NITROIMIDAZOLE DERIVATIVE; ALBENDAZOLE; BENZIMIDAZOLE; BENZIMIDAZOLE DERIVATIVE; DIMETRIDAZOLE; FLUORESCENT DYE; MEBENDAZOLE; METRONIDAZOLE; NOCODAZOLE; ORNIDAZOLE; OXIBENDAZOLE; RONIDAZOLE; SECNIDAZOLE; TIABENDAZOLE; TINIDAZOLE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CELL ASSAY; CELL KINETICS; CELL STRUCTURE; CELL SUBPOPULATION; COMPETITION; CONCENTRATION RESPONSE; CONTINUOUS CULTURE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOLOGY; DRUG ACTIVITY; DRUG EFFICACY; DRUG EXPOSURE; DRUG RESPONSE; DRUG SCREENING; GIARDIA DUODENALIS; IN VITRO STUDY; LIQUID CULTURE; MEXICO; MOLECULAR CLONING; NONHUMAN; PARASITE CULTIVATION; PARASITE ISOLATION; PARENT; PROGENY; STAINING; STANDARD; TROPHOZOITE;

ANIMALS; ANTIPROTOZOAL AGENTS; BENZIMIDAZOLES; CELL ADHESION; CLONING, MOLECULAR; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE; GIARDIA; GIARDIASIS; HUMANS; INHIBITORY CONCENTRATION 50; NITROIMIDAZOLES;

EID: 6344255053     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkh388     Document Type: Article

References (47)

1. Adam, R. D. (2001). Biology of Giardia lamblia. Clinical Microbiology Reviews 14, 447-75.
2. Gardner, T. B. & Hill, D. R. (2001). Treatment of giardiasis. Clinical Microbiology Reviews 14, 114-28.
3. Harris, J. C., Plummer, S. & Lloyd, D. (2001). Antigiardial drugs. Applied Microbiology and Biotechnology 57, 614-9.
4. Rodríguez-García, R., Rodríguez-Guzmán, L. M. & Cruz del Castillo, A. H. (1999). Effectiveness and safety of mebendazole compared to nitazoxanide in the treatment of Giardia lamblia in children. Revista Gastroenterológica de México 64, 122-6.
5. Abboud, P., Lemée, V., Gargala, G. et al. (2001). Successful treatment of metronidazole- and albendazole-resistant giardiasis with nitazoxanide in a patient with acquired immunodeficiency syndrome. Clinical Infectious Diseases 32, 1792-4.
6. Mendelson, R. M. (1980). The treatment of giardiasis. Transactions of the Royal Society of Tropical Medicine and Hygiene 74, 438-9.
7. Gordts, B., Hemelhof, W., Asselman, C. et al. (1985). In vitro susceptibilities of 25 Giardia lamblia isolates of human origin to six commonly used antiprotozoal agents. Antimicrobial Agents and Chemotherapy 28, 378-80.
8. Boreham, P. F. L., Smith, N. C. & Shepherd, R. W. (1988). Drug resistance and the treatment of giardiasis. In Advances in Giardia Research (Wallis, P. M. & Hammond, B. R. Eds), pp. 3-7. University of Calgary Press, Calgary, Canada.
9. Kollaritsch, H., Jeschko, E. & Wiedermann, G. (1993). Albendazole is highly effective against cutaneous larva migrans but not against Giardia infection: results of a open pilot trial in travellers returning from the tropics. Transactions of the Royal Society of Tropical Medicine and Hygiene 87, 689.
10. Brasseur, P. & Favennec, L. (1995). Two cases of giardiasis unsuccessfully treated by albendazole. Parasite 2, 422.
11. Boreham, P. F. L., Phillips, R. E. & Shepherd, R. W. (1987). Heterogeneity in the response of clones of Giardia intestinalis to antigiardial drugs. Transactions of the Royal Society of Tropical Medicine and Hygiene 81, 406-7.
12. Majewska, A. C., Kasprzak, W., De Jonckheere, J. F. et al. (1991). Heterogeneity in the sensitivity of stocks and clones of Giardia to metronidazole and ornidazole. Transactions of the Royal Society of Tropical Medicine and Hygiene 85, 67-9.
13. Farbey, M. D., Reynoldson, J. A. & Thompson, R. C. (1995). In vitro drug susceptibility of 29 isolates of Giardia duodenalis from humans as assessed by an adhesion assay. International Journal for Parasitology 25, 593-9.
14. Boreham, P. F. L., Phillips, R. E. & Shepherd, R. W. (1984). The sensitivity of Giardia intestinalis to drugs in vitro. Journal of Antimicrobial Chemotherapy 14, 449-61.
15. Wahl, S. M., Gilman, R. H., O'Hare, J. et al. (1988). A new miniculture technique for determining in vitro antimicrobial agent sensitivity of axenically cultivated strains of Giardia lamblia. In Advances in Giardia Research (Wallis, P. M. & Hammond, B. R. Eds), pp. 21-4. University of Calgary Press, Calgary, Canada.
16. Cedillo-Rivera, R. & Muñoz, O. (1992). In vitro susceptibility of Giardia lamblia to albendazole, mebendazole and other chemotherapeutic agents. Journal of Medical Microbiology 37, 221-4.
17. Kang, E. W., Clinch, K., Furneaux, R. H. et al. (1998). A novel and simple colorimetric method for screening Giardia intestinalis and anti-giardial activity in vitro. Parasitology 117, 229-34.
18. Pearce, D. A., Reynoldson, J. A. & Thompson, R. C. (1996). A comparison of two methods for assesssing drug sensitivity in Giardia duodenalis. Applied Parasitology 37, 111-6.
19. Sousa, M. C. & Poiares-Da-Silva, J. (1999). A new method for assessing metronidazole susceptibility of Giardia lamblia trophozoites. Antimicrobial Agents and Chemotherapy 43, 2939-42.
20. Cruz, A., Isaura-Sousa, M., Azeredo, Z. et al. (2003). Comparison between two common methods for measuring Giardia lamblia susceptibility to antiparasitic drugs in vitro. Acta Tropica 88, 131-5.
21. Meloni, B. P., Thompson, R. C., Reynoldson, J. A. et al. (1990). Albendazole: a more effective antigiardial agent in vitro than metronidazole or tinidazole. Transactions of the Royal Society of Tropical Medicine and Hygiene 84, 375-9.
22. Edlind, T. D., Hang, T. L. & Chakraborty, P. R. (1990). Activity of the antihelmintic benzimidazoles against Giardia lamblia in vitro. Journal of Infectious Diseases 162, 1408-11.
23. Katiyar, S. K., Gordon, V. R., McLaughlin, G. L. et al. (1994). Antiprotozoal activities of benzimidazoles and correlations with beta-tubulin sequence. Antimicrobial Agents and Chemotherapy 38 2086-90.
24. Thompson, R. C. A. & Meloni, B. P. (1993). Molecular variation in Giardia. Acta Tropica 53, 167-84.
25. Cedillo-Rivera, R., Enciso-Moreno, J. A., Martínez-Palomo, A. et al. (1991). Isolation and axenization of Giardia lamblia isolates from symptomatic and asymptomatic patients in Mexico. Archivos de Investigación Médica 22, 79-85.
26. Cedillo-Rivera, R., Darby, J. M., Enciso-Moreno, J. A. et al. (2003). Genetic homogeneity of axenic isolates of Giardia intestinalis derived from acute and chronically infected individuals in Mexico. Parasitology Research 90, 119-23.
27. Baum, K. F., Berens, R. L., Jones, R. H. et al. (1988). A new method for cloning Giardia lamblia, with a discussion of the statistical considerations of limiting dilution. Journal of Parasitology 74, 267-9.
28. Keister, D. B. (1983). Axenic culture of Giardia lamblia in TYIS-33 medium supplemented with bile. Transacions of the Royal Society of Tropical Medicine and Hygiene 77, 487-8.
29. Gillin, F. D. & Diamond, L. S. (1981). Inhibition of clonal growth of Giardia lamblia and Entamoeba histolytica by metronidazole, quinacrine, and other antimicrobial agents. Journal of Antimicrobial Chemotherapy 8, 305-16.
30. Gillin, F. D. & Reiner, D. S. (1982). Effects of oxygen tension and reducing agents on sensitivity of Giardia lamblia to metronidazole in vitro. Biochemical Pharmacology 31, 3694-7.
31. Hill, D. R., Pohl, R. & Pearson, R. D. (1986). Giardia lamblia: a culture method for determining parasite viability. American Journal of Tropical Medicine and Hygiene 35, 1129-33.
32. Wright, C. W., Melwani, S. I., Phillipson, J. D. et al. (1992). Determination of anti-giardial activity in vitro by means of soluble formazan production. Transactions of the Royal Society of Tropical Medicine and Hygiene 86, 517-9.
33. Schupp, D. G. & Erlandsen, S. L. (1987). A new method to determine Giardia cyst viability: correlation of fluorescein diacetate and propidium iodide staining with animal infectivity. Applied and Environmental Microbiology 73, 704-7.
34. Jones, K. H. & Senft, J. A. (1985). An improved method to determine cell viability by simultaneous staining with fluorescein diacetate-propidium iodide. Journal of Histochemistry and Cytochemistry 33, 77-9.
35. Favennec, L., Chochillon, C., Magne, D. et al. (1992). A new screening assay for antigiardial compounds: effect of various drugs on the adherence of Giardia duodenalis to CaCo2 cells. Parasitology Research 78, 80-1.
36. Inge, P. M. G. & Farthing, M. J. G. (1987). A radiometric assay for antigiardial drugs. Transactions of the Royal Society of Tropical Medicine and Hygiene 81, 345-7.
37. Humphreys, M. J., Allman, R. & Lloyd, D. (1994). Determination of the viability of Trichomonas vaginalis using flow cytometry. Cytometry 15, 343-8.
38. Nasirudeen, A. M., Tan, K. S., Singh, M. et al. (2001). Programmed cell death in a human intestinal parasite, Blastocystis hominis. Parasitology 123, 235-46.
39. Dias, N. & Lima, N. (2002). A comparative study using a fluorescence-based and a direct-count assay to determine cytotoxicity in Tetrahymena piriformis. Research in Microbiology 153, 313-22.
40. Boreham, P. F. L., Phillips, R. E. & Shepherd, R. W. (1986). The activity of drugs against Giardia intestinalis in neonatal mice. Journal of Antimicrobial Chemotherapy 18, 393-8.
41. Reynoldson, J. A., Thompson, R. C. A. & Meloni, B. P. (1991). In vivo efficacy of albendazole against Giardia duodenalis in mice. Parasitology Research 77, 325-8.
42. Lemée, V., Zaharia, I., Nevez, G. et al. (2000). Metronidazole and albendazole susceptibility of 11 clinical isolates of Giardia duodenalis from France. Journal of Antimicrobial Chemotherapy 46, 819-21.
43. Thompson, R. C. A., Lymbery, A. J., Pearce, D. A. et al. (1996). Giardia duodenalis: exposure to metronidazole inhibits competitive interactions between isolates of the parasite in vitro. Journal of Parasitology 82, 679-83.
44. Rousham, E. K. (1994). An increase in Giardia duodenalis infection among children receiving periodic antihelmintic treatment in Bangladesh. Journal of Tropical Pediatrics 40, 329-33.
45. Townson, S. M., Laqua, H., Upcroft, P. et al. (1992). Induction of metronidazole and furazolidone resistance in Giardia. Transactions of the Royal Society of Tropical Medicine and Hygiene 86, 521-2.
46. MacGowan, A. P. & Wise, R. (2001). Establishing MIC break-points and the interpretation of in vitro susceptibility tests. Journal of Antimicrobial Chemotherapy 48, 17-28.
47. Nash, T. E. (2002). Surface antigenic variation in Giardia lamblia. Molecular Microbiology 45, 585-90.